Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures

Journal of Neurochemistry

Volumn 91, Issue 5, 2004, Pages 1211-1218

  Ding, Qunxing ^a   Dimayuga, Edgardo ^a   Markesbery, William R ^a   Keller, Jeffrey N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

8 hydroxy 2 deoxyguanosine; 8 OHdG; Aging; Alzheimer's disease; Oxidative stress; Proteasome

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA; GUANOSINE DERIVATIVE; PROTEASOME; PROTEASOME INHIBITOR; RIBOSOME RNA; RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL TYPE; CONTROLLED STUDY; CROSS LINKING; IMMUNOREACTIVITY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BORONIC ACIDS; BRAIN; CELLS, CULTURED; DEOXYADENOSINES; DNA; EMBRYO; GUANOSINE; IMMUNOHISTOCHEMISTRY; LEUPEPTINS; NEURONS; OXIDATION-REDUCTION; PROTEASE INHIBITORS; RATS; RNA; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 28S; TIME FACTORS;

ANIMALIA; EUKARYOTA;

EID: 9744223523     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02802.x     Document Type: Article

References (44)

1. Al-Abdulla N. A. and Martin L. J. (1998) Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am. J. Pathol. 153, 447-456.
2. Berke S. J. and Paulson H. L. (2003) Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr. Opin. Genet. Dev. 13, 253-261.
3. Butterfield D. A. and Categna A. (2003) Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration. Cell Mol. Biol. (Noisy-le-Grand) 49, 747-751.
4. Ding Q. and Keller J. N. (2001) Proteasomes and proteasome inhibition in the central nervous system. Free Radic. Biol. Med. 31, 574-584.
5. Ding Q., Dimayuga E., Martin S., Bruce-Keller A. J., Nukala V., Cuervo A. M. and Keller J. N. (2003) Characterization of chronic low-level proteasome inhibition on neural homeostasis. J. Neurochem. 86, 489-497.
6. Fiala E. S., Conaway C. C. and Mathis J. E. (1989) Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res. 49, 5518-5522.
7. Gabbita S. P., Lovell M. A. and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 2034-2040.
8. Gee J., Ding Q. and Keller J. N. (2002) Analysis of Werner's expression within the brain and primary neuronal culture. Brain Res. 940, 44-48.
9. Goldberg A. L., Akopian T. N., Kisselev A. F., Lee D. H. and Rohrwild M. (1997) New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol. Chem. 378, 131-140.
10. Gozal D., Row B. W., Kheirandish L., Liu R., Guo S. Z., Qiang F. and Brittian K. R. (2003) Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function. J. Neurochem. 86, 1545-1552.
11. Kasai H., Chung M. H., Jones D. S., Inoue H., Ishikawa H., Kimiya H., Ohtsuka E. and Nishimura S. (1991) 8-Hydroxyguanine, a DNA adduct formed by oxygen radicals: its implications on oxygen radical-involved mutagenesis/carcinogenesis. J. Toxicol. Sci. 16, 95-105.
12. Keller J. N. and Markesbery W. R. (2000) Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death. J. Neurosci. Res. 61, 436-442.
13. Keller J. N., Huang F. F. and Markesbery W. R. (2000a) Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98, 149-156.
14. Keller J. N., Hanni K. B. and Markesbery W. R. (2000b) Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 113, 61-70.
15. Keller J. N., Hanni K. B. and Markesbery W. R. (2000c) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
16. Keller J. N., Huang F. F., Dimayuga E. R. and Maragos W. F. (2000d) Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic. Biol. Med. 29, 1037-1042.
17. Keller J. N., Gee J. and Ding Q. (2002) The proteasome in brain aging. Ageing Res. Rev. 1, 279-293.
18. Liu J., Head E., Gharib A. M., Yuan W., Ingersoll R. T., Hagen T. M., Cotman C. W. and Ames B. N. (2002) Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-camitine and/or R-alpha-lipoic acid. Proc. Natl Acad. Sci. USA 99, 2356-2361.
19. Lopez-Salon M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
20. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
21. Markesbery W. R. and Camey J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133-146.
22. McBride W. H., Iwamoto K. S., Syljuasen R., Pervan M. and Pajonk F. (2003) The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene 22, 5755-5773.
23. McNaught K. S. and Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194.
24. McNaught K. S., Belizaire R., Isacson O., Jenner P. and Olanow C. W. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38-46.
25. Montine K. S., Kim P. J., Olson S. J., Markesbery W. R. and Montine T. J. (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56, 866-871.
26. Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S. and Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19, 1959-1964.
27. Nunomura A., Perry G., Pappolla M. A., Friedland R. P., Hirai K., Chiba S. and Smith M. A. (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59, 1011-1017.
28. Nunomura A., Chiba S., Kosaka K., Takeda A., Castellani R. J., Smith M. A. and Perry G. (2002) Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 13, 2035-2039.
29. Park E. M., Shigenaga M. K., Degan P., Korn T. S., Kitzler J. W., Wehr C. M., Kolachana P. and Ames B. N. (1992) Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc. Natl Acad. Sci. USA 89, 3375-3379.
30. Perry G., Nunomura A., Hirai K. et al. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475-1479.
31. Picklo M. J., Montine T. J., Amarnath V. and Neely M. D. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187-197.
32. Qiu J. H., Asai A., Chi S., Saito N., Hamada H. and Kirino T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259-265.
33. Rideout H. J. and Stefanis L. (2002) Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol. Cell Neurosci. 21, 223-238.
34. Rideout H. J., Wang Q., Park D. S. and Stefanis L. (2003) Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J. Neurosci. 23, 1237-1245.
35. Sayre L. M., Smith M. A. and Perry G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8, 721-738.
36. Shan X., Tashiro H. and Lin C. L. (2003) The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 23, 4913-4921.
37. Stadtman E. R. (2001) Protein oxidation in aging and age-related diseases. Ann. N. Y. Acad. Sci. 928, 22-38.
38. Sullivan P. G., Dragicevic N. B., Deng J. H., Bai Y., Dimayuga E., Ding Q., Chen Q., Bruce-Keller A. J. and Keller J. N. (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279, 20 699-20 707.
39. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T. and Davies K. J. (1999) Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl Acad. Sci. USA 96, 6223-6228.
40. Walters K. J., Lech P. J., Goh A. M., Wang Q. and Howley P. M. (2003) DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a. Proc. Natl Acad. Sci. USA 100, 12 694-12 699.
41. Wamer W. G., Yin J. J. and Wei R. R. (1997) Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic. Biol. Med. 23, 851-858.
42. Yin B., Whyatt R. M., Perera F. P., Randall M. C., Cooper T. B. and SanTella R. M. (1995) Determination of 8-hydroxydeoxyguanosine by immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic. Biol. Med. 18, 1023-1032.
43. Zhang J., Perry G., Smith M. A., Robertson D., Olson S. J., Graham D. G. and Montine T. J. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423-1429.
44. Zhu X., Raina A. K., Lee H. G., Casadesus G., Smith M. A. and Perry G. (2004) Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000, 32-39.